Post Subject #707   ABBV 1Q22 CC transcript: DewDiligence 05/01/22 01:58:44 PM #706   Didn't expect that. Bailed and wiped out most retired early 04/29/22 10:46:17 AM #705   ABBV 1Q22 results: DewDiligence 04/29/22 08:29:28 AM #704   Or perhaps we are done correcting? :) retired early 04/27/22 03:29:46 PM #703   Thanks DewDilligence, you are most likely right about Just the facts maam 04/25/22 07:18:19 AM #702   Androgel is now available as a generic, so DewDiligence 04/24/22 11:56:36 AM #701   Question for the board, is AbbVie interested in Just the facts maam 04/24/22 07:05:00 AM #700   Up too fast perhaps. Maybe a new 120 base? retired early 04/17/22 11:58:23 AM #699   ABBV Chart conix 04/17/22 08:46:09 AM #698   ABBV’s #2 executive, Mike Severino, is leaving to DewDiligence 04/13/22 12:27:08 PM #697   Wow a $13 mil buy @ end retired early 04/03/22 10:42:52 AM #696   FDA approves Rinvoq for second-line ulcerative colitis: DewDiligence 03/16/22 08:40:47 PM #695   Recent investor. Looks like a safer long term retired early 03/15/22 11:19:48 AM #694   ABBV reports positive Qulipta phase-3 in prevention of DewDiligence 03/10/22 09:34:31 AM #693   Alvotech settles Humira-US-patent litigation with ABBV: DewDiligence 03/08/22 07:33:11 PM #692   Skyrizi PDUFA date for Crohn’s disease extended three DewDiligence 02/28/22 07:32:11 PM #691   Rinvoq succeeds in second Phase-3 in Crohn’s: DewDiligence 02/24/22 11:48:04 AM #690   ATH! lilLu 02/03/22 10:13:26 AM #689   Looking Great! lilLu 02/02/22 11:15:51 PM #688   ABBV pipeline: DewDiligence 02/02/22 09:00:40 AM #687   ABBV 4Q21 results: DewDiligence 02/02/22 08:59:46 AM #686   ABBV chart oxnous 01/14/22 09:42:06 PM #685   FDA approves Rinvoq for second-line atopic dermatitis: DewDiligence 01/14/22 01:48:26 PM #684   ABBV JPM slide set: DewDiligence 01/11/22 07:54:14 PM #683   FDA approves Rinvoq for second-line psoriatic arthritis: DewDiligence 12/14/21 07:07:34 PM #682   Rinvoq hits_primary/secondary_endpoints_in phase-3 trial_in_second-line Crohn’s DewDiligence 12/06/21 11:20:18 AM #681   JAK inhibitors—including ABBV’s Rinvoq and PFE’s Xeljanz—have new DewDiligence 12/03/21 06:47:54 PM #680   https://seekingalpha.com/article/4465863-abbvie-abbv-undervalued-dividend-growth lilLu 11/05/21 06:58:14 PM #679   Whatever happened to Michael Jordan drug free commercials?...Stop lilLu 11/03/21 09:04:35 AM #678   Also the confusion of what is a real lilLu 11/03/21 08:58:05 AM #677   Exactly. You'd be surprised how many peeps would lilLu 11/03/21 08:37:04 AM #676   Just to be clear, some doctors share the trkyhntr 11/03/21 06:15:15 AM #675   Never understood how marketing campaigns can be linked lilLu 11/03/21 12:44:40 AM #674   And divi's still going strong! ITS A BUY! lilLu 11/03/21 12:41:11 AM #673   FDA approves ABBV’s Vuity—(pilocarpine eye drops)—for presbyopia: DewDiligence 10/29/21 06:55:29 PM #672   ABBV 3Q21 CC transcript: DewDiligence 10/29/21 04:26:08 PM #671   ABBV 3Q21 results: DewDiligence 10/29/21 08:43:28 AM #670   You beat me to it. Still a great lilLu 10/29/21 08:28:35 AM #669   AbbVie Stock Gains After Hiking FY21 Earnings Outlook, fuzzy 10/29/21 08:25:49 AM #668   Oct 29th. 3rd quarter earnings. lilLu 10/19/21 09:24:58 PM #667   FDA approves first interchangeable Humira biosimilar—from B-I: DewDiligence 10/18/21 03:09:03 PM #666   https://seekingalpha.com/article/4459620-abbvie-top-dividend-stock-for-long-term lilLu 10/13/21 02:00:30 PM #665   https://seekingalpha.com/article/4458461-abbvie-appears-ready-to-reverse-and-out lilLu 10/08/21 02:49:03 AM #664   FDA approves ABBV’s Qulipta—(atogepant)—for migraine prevention: DewDiligence 09/29/21 09:15:43 AM #663   https://www.fool.com/investing/2021/09/27/could-abbvies-new-collaboration-be-a-b lilLu 09/28/21 10:24:30 PM #662   https://www.fiercebiotech.com/biotech/abbvie-bets-370m-pivotal-eye-disease-gene- lilLu 09/14/21 01:24:26 AM #661   https://www.thestreet.com/investing/abbvie-could-be-good-defensive-play lilLu 09/06/21 11:15:21 PM #660   ABBV -8% on_new_FDA-label_warnings_for JAK inhibitors_including Rinvoq: DewDiligence 09/01/21 12:25:26 PM #659   https://www.fool.com/investing/2021/08/15/better-dividend-stock-abbvie-or-pfizer lilLu 08/16/21 03:20:58 AM #658   https://www.fool.com/investing/2021/08/10/3-key-takeaways-from-abbvies-second-qu lilLu 08/10/21 07:24:42 PM Post Subject

© 2022 InvestorsHub.com, Inc.